PFE Pfizer Dashboard

Pfizer applies science and its global resources to bring therapies to people that extend and significantly improve their lives. It strives to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with its responsibility as one of the world's premier innovative biopharmaceutical companies, it collaborates with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, it has worked to make a difference for all who rely on it. It routinely posts information that may be important to investors on its website at www.Pfizer.com.

Company profile

Ticker

PFE

Exchange

NYSE

Website

www.pfizer.com/

CEO

Albert Bourla

Incorporated

Delaware

Location

New York

Fiscal year end

Dec 31

Sector

Manufacturing > Pharmaceutical Preparation Manufacturing

Industry (SIC)

Pharmaceutical Preparations

Johnson & Johnson • Merck & Co • Allergan • Abbott Laboratories • Teva- Pharmaceutical Industries • Lilly(Eli) & Co • Viatris • Bristol-Myers Squibb • Warner Chilcott • Abbvie ...

SEC CIK

0000078003

Corporate docs

Articles of Incorporation & Bylaws

PFE stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

Benzinga's Bulls And Bears Of The Week: Apple, Amazon, Kroger, Netflix, Pfizer And More

8 May 21

Benzinga has examined the prospects for many of investors' favorite stocks over the past week. The past week's bullish calls included a couple of FAANG stocks and a company that just took a big hit.

COVID-19 Vaccine Patent Polarizes The World: What You Need To Know

7 May 21

The COVID-19 pandemic is continuing to rage unabated. Just as countries across the globe were coming online from a protracted lockdown, the second and third wave of the pandemic is threatening to derail hopes of a return to a more normal way of life. It's against this backdrop that vaccines and treatments options have taken center stage.

EMA Safety Committee Reviews Heart Inflammation, Rare Nerve Disorder Reports After Pfizer, AstraZeneca COVID-19 Shots

7 May 21

European Medical Agency (EMA) is reviewing reports of a rare nerve-degenerating disorder in people who received AstraZeneca P

Pfizer And BioNTech Seek FDA's Full Approval For COVID-19 Vaccine

7 May 21

Pfizer, BioNTech Report Initiation Of Rolling Submission Of Biologics License Application For US FDA Approval Of COVID-19 Vaccine

7 May 21

Press releases

Pro users get this 30m faster

Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of their COVID-19 Vaccine

7 May 21

NEW YORK and MAINZ, GERMANY, May 7, 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) today announced the initiation of a Biologics License Application (BLA) with the U.S. Food and Drug

Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of Their COVID-19 Vaccine

7 May 21

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) today announced the initiation of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for approval of their mRNA vaccine to prevent

Thinking about trading options or stock in Apple, Pfizer, BioNTech, Sally Beauty Holdings, or Paypal?

6 May 21

NEW YORK, May 6, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, PFE, BNTX, SBH, and PYPL.

Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games

6 May 21

Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games

6 May 21

Calendar

25 Feb 21

9 May 21

31 Dec 21

Financial summary

Financial statements Chart PFE financial data

Quarter (USD)	Dec 20	Sep 20	Jun 20	Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Pfizer earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	1.83B	1.83B	1.83B	1.83B	1.83B	1.83B
Cash burn (monthly)	(positive/no burn)	(positive/no burn)	839M	(positive/no burn)	(positive/no burn)	(positive/no burn)
Cash used (since last report)	n/a	n/a	3.59B	n/a	n/a	n/a
Cash remaining	n/a	n/a	-1.76B	n/a	n/a	n/a
Runway (months of cash)	n/a	n/a	-2.1	n/a	n/a	n/a

Beta Read what these cash burn values mean

Recent insider trades

PFE insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
5 May 21	Jennifer B. Damico	Common Stock	Sell	Dispose S	No	No	40.82	2,500	102.05K	13,748
30 Apr 21	John D Young	Phantom Stock Units SSP Common Stock	Grant	Aquire A	No	No	38.65	11	425.15	52,247
30 Apr 21	Rady A Johnson	Phantom Stock Units SSP Common Stock	Grant	Aquire A	No	No	38.65	4	154.6	6,509
30 Apr 21	Jennifer B. Damico	Phantom Stock Units SSP Common Stock	Grant	Aquire A	No	No	38.65	32	1.24K	14,244
30 Apr 21	Albert Bourla	Phantom Stock Units SSP Common Stock	Grant	Aquire A	No	No	38.65	13	502.45	87,663

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2020

PFE institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

66.2% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	2586	2452	+5.5%
Opened positions	293	185	+58.4%
Closed positions	159	115	+38.3%
Increased positions	1223	1119	+9.3%
Reduced positions	885	920	-3.8%

13F shares	Current	Prev Q	Change
Total value	136.05B	139.52B	-2.5%
Total shares	3.69B	3.76B	-1.7%
Total puts	56.14M	39.73M	+41.3%
Total calls	63.75M	40.73M	+56.5%
Total put/call ratio	0.9	1.0	-9.7%

Largest owners	Shares	Value	Change
Vanguard	447.96M	$16.49B	-0.7%
BLK Blackrock	396.97M	$14.61B	-4.3%
STT State Street	279.58M	$10.29B	-3.3%
Capital World Investors	266.65M	$9.82B	+2.9%
Wellington Management	246.49M	$9.07B	+5.0%
Geode Capital Management	90.45M	$3.32B	+1.4%
BAC Bank Of America	68.49M	$2.52B	-15.3%
NTRS Northern Trust	66.72M	$2.46B	-2.8%
BK Bank Of New York Mellon	64.76M	$2.38B	+12.1%
Norges Bank	60.3M	$2.22B	NEW

Largest transactions	Shares	Bought/sold	Change
Norges Bank	60.3M	+60.3M	NEW
BLK Blackrock	396.97M	-17.79M	-4.3%
MCQEF Macquarie	4.05M	-17.75M	-81.4%
Lazard Asset Management	3.34M	-14.02M	-80.8%
BAC Bank Of America	68.49M	-12.35M	-15.3%
Wellington Management	246.49M	+11.75M	+5.0%
STT State Street	279.58M	-9.51M	-3.3%
AMP Ameriprise Financial	8.49M	-8.77M	-50.8%
TROW T. Rowe Price	31.55M	-8.19M	-20.6%
MS Morgan Stanley	53.61M	+7.54M	+16.4%

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Akorn • TherapeuticsMD • GT Biopharma • Church & Dwight • Teligent • Celldex Therapeutics • Acura Pharmaceuticals • Immucell • Heron Therapeutics • Brickell Biotech

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: AAH, AbbVie, ABO, Abrilada, absolute, academic, Academy, accompanying, accrual, acetate, actuarial, adjacent, adolescent, ADP, adult, Advair, affirmed, agricultural, Aid, allegedly, Allergan, alongside, Amgen, AML, amortization, amortize, amortized, AMPA, amplified, amplify, amplifying, Amsparity, Ankylosing, anonymity, antagonist, anytime, AOCI, apixaban, Appellate, ARCA, arrive, ARYA, ASR, assign, assigned, assumption, atopic, attained, Aug, Aurobindo, autoinjector, Automatically, automation, avoidance, aware, bacteria, Baltimore, Bankruptcy, barring, behavior, beneficiary, bevacizumab, Biden, billed, binding, binimetinib, BIO, Biogen, BioNTech, BOD, body, Bold, bond, book, booster, Bosulif, Bound, breakthrough, breast, Bresch, brick, brightest, Brook, buy, buying, Cadila, Calcium, CAR, Carapezzi, cardiac, Carlo, castration, causation, CDC, cease, ceased, CERE, certified, cessation, cetuximab, Chapter, characterize, charitable, chemotherapy, Citibank, Citrate, clarifying, clothing, cloud, CMA, collateral, colleague, Colorado, Columbia, commingled, complaint, composite, composition, conjunction, Connecticut, consecutive, conservative, correlate, correlation, corridor, corroborated, Cortexyme, counterbalance, counterclaim, counterparty, coupon, courage, COVAX, Crohn, crystalline, CStone, culmination, cumulative, curtailed, Cyanamid, cycle, cytarabine, daily, damico, deadline, Dec, deconsolidated, decree, deep, defense, delinquency, delisted, denial, derecognition, derecognized, destroyed, device, disallowance, discharge, discriminating, disgorgement, dismissed, dismissing, disputed, diversification, diversified, dividend, Docetaxel, double, doughnut, DRG, EEA, ehf, Eli, EMD, emotional, empowering, enantiomer, encorafenib, endpoint, energized, engineering, England, enjoining, enrichment, enrollment, enzalutamide, EPA, epidemiological, epinephrine, EpiPen, EPS, equate, Erbitux, erode, error, ertugliflozin, ESG, ESOP, estate, estradiol, ethnic, ethnically, EUA, evenly, examined, examining, excellence, exempt, exemption, exhausted, expedient, experiential, expressed, fairly, FASB, feasibility, feasible, Feb, feedback, feel, fiduciary, filer, finite, flat, fleet, Florida, forfeited, forfeiture, FORMSFOR, formula, Fosun, France, franchise, French, froze, fusion, futility, GAAP, GDFV, gender, gene, geopolitical, germline, Glenmark, GmbH, GnRH, Governor, great, groundwater, guarantor, guideline, hair, handling, Haven, healthy, heard, hearing, Heather, Hexal, hierarchy, highest, HIPAA, HIV, hole, Hong, honoring, hyperinflationary, hypothetical, Idec, idiopathic, illiquid, ImClone, immaterial, immunodeficiency, implicit, implied, Imputed, inception, incidence, incremental, indefinite, indefinitely, indemnified, indemnify, indemnifying, indemnity, indirectly, induced, inestimable, Infant, infection, infiltration, inflationary, influenza, ingestion, inhalation, Inhub, Inquiry, installment, institution, interdicting, intermediary, interval, intraperiod, intrinsic, invasive, inventory, investee, invoice, invoiced, Iraqi, IRC, Irrungattukottai, IRS, ISDA, Jan, jennifer, job, joy, JPO, judgment, Justice, justifying, JV, JVs, Kadian, King, Kong, KPMG, krona, lag, lagged, learning, length, lieu, Lilly, listening, loan, LOE, Lorbrena, Louisiana, lump, lung, Lyme, MA, Macau, macroeconomic, MaddenSenior, mainland, maker, malware, managerial, margin, mask, master, maximum, Mayor, mCRC, mCRPC, MDL, meant, melanoma, mental, mentioned, mentoring, merged, merit, methodology, methotrexate, mg, misrepresented, Mississippi, misstatement, Monsanto, Monte, Monthly, Moody, mortality, mortar, motion, movement, mRNA, multidistrict, Myovant, NaN, NASDAQ, NAV, NDMA, nearest, Neratinib, neuropathic, Neutropenia, NHS, nmCRPC, noncontrolling, noncurrent, norethindrone, Northern, notch, notional, Nov, NRDL, NSCLC, NYU, Nyvepria, obligor, observable, observational, observed, OCI, Oct, Ohio, OID, onForm, onsite, Opiate, OPKO, Optical, Orange, orderly, Orgovyx, outlook, overfunded, Overnight, overseen, owing, PAC, palbociclib, pandemic, Panzyga, paper, par, parent, pause, payable, Payal, payor, payout, PBO, PCAOB, PCPP, permanent, perpetual, perspective, petition, Pharmacia, phishing, phosphate, PIPE, plaintiff, poly, polychlorinated, polymerase, polymorphic, pool, powder, precipitate, precision, predecessor, predetermined, predominately, pregabalin, prejudice, preliminarily, preserve, pro, prodrug, propionate, proportion, proportionately, prorated, protease, proton, proud, provable, provisional, PTC, PTE, PTSRU, Pulse, Puma, pump, punitive, purported, purportedly, purpura, quantifying, Quillivant, quoted, RA, race, Racketeer, radio, Ranbaxy, RAR, Raritan, rata, reader, ready, reallocated, reallocating, recasting, reclassification, reconciling, recoup, recouped, recover, recoverability, recoverable, recovered, recurring, Reddy, redeem, redeemable, redeemed, redemption, reevaluate, refill, refund, refunded, reliant, relugolix, remeasured, remeasurement, remittance, remitted, remote, remotely, renegotiation, rent, rental, reoccur, repay, reserve, reserved, Residual, resiliency, restarted, restitution, RET, retiree, retirement, retrospective, retrospectively, ribose, Rican, rituximab, River, rivipansel, Roche, ROU, royalty, RSC, Russian, Sahni, salmeterol, Sandoz, Sanofi, Sawai, scale, Scheme, Scotland, Scottish, SDNY, SecretaryChief, sentence, Sept, Serono, Servier, Shanghai, shelf, shipment, Shire, shorter, shown, Sildenafil, simpler, simulation, SIP, skill, SOFR, Solutia, sought, Southern, sovereign, Spain, span, SPC, speak, spinal, spot, stable, statewide, statute, statutory, stay, stayed, stemming, stream, strict, sublease, subpoena, subscription, substantive, sued, sugemalimab, Sugen, sum, summarized, superior, superseded, Supreme, survey, suspend, suspended, Sweden, Swedish, syncytial, tablet, Tadalafil, Taiwan, talazoparib, talent, talented, Talzenna, taxable, Taxotere, temperature, temporary, therefrom, thereunder, threshold, thrive, thrombocytopenic, ticker, title, tofacitinib, tolerability, tolerance, Topic, traditional, transmission, travel, Treadway, treble, troubled, TSRU, turnover, TV, twelve, UC, UK, unbudgeted, unchanged, underfunded, underrepresented, underserved, undertaken, underwritten, undiscounted, unduly, unemployment, unforeseen, unissued, unjust, unlawful, unlisted, unobservable, unpaid, unpatented, unprecedented, unqualified, unrealized, unrecognized, unrelated, unremitted, unsecured, unsettled, unused, unvested, upheld, upward, USP, Uterine, Valneva, variation, veto, vi, Virginia, virtual, virtually, visit, vitro, voluntarily, volunteering, Vyndamax, Vyndaqel, wake, war, warrant, weighted, West, whichever, wholly, William, Wixela, WMS, write, XR, Zantac

Removed: absence, accretion, accumulator, acting, addressed, adulteration, advertised, advice, affiliate, ambiguity, Andover, Appendix, Apple, attached, attempt, authentic, backlog, balanced, bear, cangialosi, cap, cautionary, ceiling, CETA, chemically, clarity, combining, conjugate, consolidating, constantly, Conversely, coordinating, cornwell, counteract, counterfeiting, coupled, crime, Decentralized, deliberately, detected, dictate, disciplined, disguising, distinguish, diversion, don, downturn, draft, easier, easily, economical, electorate, enhancement, evade, eventually, evidentiary, exacerbated, expediting, faced, facilitated, facing, favoring, Federation, firmly, foreseen, gaining, good, harmonizing, heavy, heighten, hyperlinked, ian, Iceland, identity, imported, impractical, inactive, inconsistent, Indian, inspection, intensity, interchangeability, intermediate, interpret, introducing, invalidate, involvement, iran, ITRSHRA, lacking, leading, leveraging, Liechtenstein, lifespan, Likewise, linkage, locate, longstanding, loretta, makeup, matched, matrix, McPherson, mind, MINE, minimal, mislabeled, mounting, multinational, Mutual, Norway, notable, nurse, paradigm, passage, patentability, pave, pendency, pertinent, postal, posting, preclude, premium, presidential, priority, prohibit, prosecute, provincial, punishable, put, reaction, reauthorized, recall, recombinant, referendum, referring, released, repeal, resist, Revatio, revoke, safeguard, serialization, shifting, ship, show, simplifying, skip, solvency, sound, source, steeper, step, streamlining, striving, substandard, sufficiency, sui, supplying, supporting, switch, syria, tendency, textual, theft, therapeutically, therewith, tier, top, trace, training, Translational, transport, Tree, Unaudited, unavailable, unclear, understood, undue, unveiled, upgraded, user, VAI, vital, voluntary, voted, Watch, wider, Xyntha

From filing 10-K 2020 FY